StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Quoin Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.27M. For fiscal 2025 it was -$13.54M. The highest annual figure on record is -$1.30M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.54M–
FY2024Dec 31, 2024-$7.86M–
FY2023Dec 31, 2023-$7.86M–
FY2022Dec 31, 2022-$8.48M–
FY2021Dec 31, 2021-$5.72M–
FY2020Dec 31, 2020-$1.34M–
FY2019Dec 31, 2019-$1.30M–
FY2017Dec 31, 2017-$5.13M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.14M–
Q1 FY2026Mar 31, 2026-$4.87M–
Q4 FY2025Dec 31, 2025-$5.04M–
Q3 FY2025Sep 30, 2025-$2.23M–
Q2 FY2025Jun 30, 2025-$3.69M–
Q1 FY2025Mar 31, 2025-$2.59M–
Q4 FY2024Dec 31, 2024-$2.24M–
Q3 FY2024Sep 30, 2024-$2.18M–
Q2 FY2024Jun 30, 2024-$2.01M–
Q1 FY2024Mar 31, 2024-$1.43M–
Q4 FY2023Dec 31, 2023-$3.22M–
Q3 FY2023Sep 30, 2023-$1.32M–
Q2 FY2023Jun 30, 2023-$1.57M–
Q1 FY2023Mar 31, 2023-$1.75M–
Q4 FY2022Dec 31, 2022-$1.94M–
Q3 FY2022Sep 30, 2022-$2.29M–
Q2 FY2022Jun 30, 2022-$2.15M–
Q1 FY2022Mar 31, 2022-$2.09M–
Q4 FY2021Dec 31, 2021-$3.18M–
Q3 FY2021Sep 30, 2021-$907.54K–

More Quoin Pharmaceuticals figures

See a number that looks wrong?